Related Experiment Video
Updated: Aug 19, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Adjunctive rifampin therapy for central nervous system staphylococcal infections
1Virginia Commonwealth University/Medical College of Virginia Campus, Richmond, VA, USA.
Objective:
To review the published clinical data assessing the role of adjunctive rifampin therapy for the treatment of staphylococcal central nervous system (CNS) infections.
Data Sources:
A MEDLINE search (January 1966-March 2000) of English-language literature pertaining to CNS staphylococcal infections and rifampin was performed; tertiary sources were also used.
Data Extraction:
Human data and case reports were included, as no clinical trials have been published.
Data Synthesis:
Retrospective reviews of rifampin used in combination with other antibiotics for serious bacterial infections show conflicting results. Few case reports have described clinical successes with adjunctive rifampin therapy for CNS infections.
Conclusions:
The routine use of adjunctive rifampin for CNS infections cannot be justified.
Related Concept Videos
Staphylococcal Skin Infections
Rocky Mountain Spotted Fever
Streptococcal Pharyngitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology

